Minimal change disease associated with anti-PD1 immunotherapy: a case report

by Bixia Gao, Ningjing Lin, Suxia Wang, Yu Wang
Published 2018-07-01

Glioblastoma Multiforme Oncogenomics and Signaling Pathways

by Okezie O. Kanu, Betsy Hughes, Chunhui Di, Ningjing Lin, Jinrong Fu, Darell D. Bigner, Hai Yan, Cory Adamson
Published 2009-01-01

Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies

by Chaoting Zhang, Heyilimu Palashati, Zhuona Rong, Ningjing Lin, Luyan Shen, Ying Liu, Shance Li, Bentong Yu, Wenjun Yang, Zheming Lu
Published 2020-11-01

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

by Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Chen Zhang, Weiping Liu, Lijuan Deng, Feifei Qi, Yanping Ding, Xin-an Lu, Yuqin Song, Jun Zhu
Published 2019-12-01

PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity

by Wen Zheng, Yuhuan Gao, Xiaoyan Ke, Weijing Zhang, Liping Su, Hanyun Ren, Ningjing Lin, Yan Xie, Meifeng Tu, Weiping Liu, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Xiaopei Wang, Yuqin Song, Jun Zhu
Published 2018-09-01

Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades

by Weiping Liu, Xinqiang Ji, Yuqin Song, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Yingli Sun, Tingting Du, Jun Zhu
Published 2020-06-01

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

by Yalu Liu, Xiaogan Wang, Lijuan Deng, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, Xiaopei Wang, Meifeng Tu, Yan Xie, Weiping Liu, Zhitao Ying, Chen Zhang, Zhengying Pan, Xi Wang, Ning Ding, Yuqin Song, Jun Zhu
Published 2019-02-01

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

by Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Chen Zhang, Weiping Liu, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Tingting Du, Feifei Qi, Xuelian Hu, Yanping Ding, Xin-an Lu, Yuqin Song, Jun Zhu
Published 2021-02-01

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group

by Weiping Liu, Yong Yang, Shunan Qi, Ying Wang, Xia He, Liling Zhang, Baolin Qu, Liting Qian, Xiaorong Hou, Xueying Qiao, Hua Wang, Gaofeng Li, Yujing Zhang, Yuan Zhu, Jianzhong Cao, Junxin Wu, Tao Wu, Suyu Zhu, Mei Shi, Liming Xu, Hang Su, Ningjing Lin, Jun Zhu, Yexiong Li, Yuqin Song
Published 2021-02-01